Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1983 Sep 10;287(6394):705–708. doi: 10.1136/bmj.287.6394.705

Endocrine myopathies.

P Kendall-Taylor, D M Turnbull
PMCID: PMC1549082  PMID: 6412791

Full text

PDF
705

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Askari A., Vignos P. J., Jr, Moskowitz R. W. Steroid myopathy in connective tissue disease. Am J Med. 1976 Oct;61(4):485–492. doi: 10.1016/0002-9343(76)90327-2. [DOI] [PubMed] [Google Scholar]
  2. CONN J. W., KNOPF R. F., NESBIT R. M. CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES. Am J Surg. 1964 Jan;107:159–172. doi: 10.1016/0002-9610(64)90252-1. [DOI] [PubMed] [Google Scholar]
  3. Carter W. J., van der Weijden Benjamin W. S., Faas F. H. Effect of experimental hyperthyroidism on skeletal-muscle proteolysis. Biochem J. 1981 Mar 15;194(3):685–690. doi: 10.1042/bj1940685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cholod E. J., Haust M. D., Hudson A. J., Lewis F. N. Myopathy in primary familial hyperparathyroidism. Clinical and morphologic studies. Am J Med. 1970 Jun;48(6):700–707. doi: 10.1016/s0002-9343(70)80004-3. [DOI] [PubMed] [Google Scholar]
  5. Clinical conference: Hyperparathyroidism: recent studies. Ann Intern Med. 1973 Oct;79(4):566–581. [PubMed] [Google Scholar]
  6. DeMartino G. N., Goldberg A. L. Thyroid hormones control lysosomal enzyme activities in liver and skeletal muscle. Proc Natl Acad Sci U S A. 1978 Mar;75(3):1369–1373. doi: 10.1073/pnas.75.3.1369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. ENGEL A. G. Thyroid function and myasthenia gravis. Arch Neurol. 1961 Jun;4:663–674. doi: 10.1001/archneur.1961.00450120077009. [DOI] [PubMed] [Google Scholar]
  8. Engel A. G. Electron microscopic observations in thyrotoxic and corticosteroid-induced myopathies. Mayo Clin Proc. 1966 Nov;41(11):785–796. [PubMed] [Google Scholar]
  9. Flaim K. E., Li J. B., Jefferson L. S. Protein turnover in rat skeletal muscle: effects of hypophysectomy and growth hormone. Am J Physiol. 1978 Jan;234(1):E38–E43. doi: 10.1152/ajpendo.1978.234.1.E38. [DOI] [PubMed] [Google Scholar]
  10. Goodhue W. W., Davis J. N., Porro R. S. Ischemic myopathy in uremic hyperparathyroidism. JAMA. 1972 Aug 21;221(8):911–912. [PubMed] [Google Scholar]
  11. Goto I. Serum creatine phosphokinase isozymes in hypothyroidism, convulsion, myocardial infarction and other diseases. Clin Chim Acta. 1974 Mar;52(1):27–30. doi: 10.1016/0009-8981(74)90384-2. [DOI] [PubMed] [Google Scholar]
  12. Grossie J., Albuquerque E. X. Extensor muscle responses to triamcinolone. Exp Neurol. 1978 Feb;58(3):435–445. doi: 10.1016/0014-4886(78)90099-7. [DOI] [PubMed] [Google Scholar]
  13. Gruener R., Stern L. Z., Payne C., Hannapel L. Hyperthyroid myopathy. Intracellular electrophysiological measurements in biopsied human intercostal muscle. J Neurol Sci. 1975 Mar;24(3):339–349. doi: 10.1016/0022-510x(75)90254-3. [DOI] [PubMed] [Google Scholar]
  14. HARTER J. G., REDDY W. J., THORN G. W. STUDIES ON AN INTERMITTENT CORTICOSTEROID DOSAGE REGIMEN. N Engl J Med. 1963 Sep 19;269:591–596. doi: 10.1056/NEJM196309192691201. [DOI] [PubMed] [Google Scholar]
  15. Hickson R. C., Davis J. R. Partial prevention of glucocorticoid-induced muscle atrophy by endurance training. Am J Physiol. 1981 Sep;241(3):E226–E232. doi: 10.1152/ajpendo.1981.241.3.E226. [DOI] [PubMed] [Google Scholar]
  16. Ianuzzo D., Patel P., Chen V., O'Brien P., Williams C. Thyroidal trophic influence on skeletal muscle myosin. Nature. 1977 Nov 3;270(5632):74–76. doi: 10.1038/270074a0. [DOI] [PubMed] [Google Scholar]
  17. Joasoo A., Murray I. P., Steinbeck A. W. Involvement of bulbar muscles in thyrotoxic myopathy. Australas Ann Med. 1970 Nov;19(4):338–340. doi: 10.1111/imj.1970.19.4.338. [DOI] [PubMed] [Google Scholar]
  18. Johnson M. A., Mastaglia F. L., Montgomery A. G., Pope B., Weeds A. G. Changes in myosin light chains in the rat soleus after thyroidectomy. FEBS Lett. 1980 Feb 11;110(2):230–235. doi: 10.1016/0014-5793(80)80080-9. [DOI] [PubMed] [Google Scholar]
  19. Kasai K. Serum myoglobin level in altered thyroid states. J Clin Endocrinol Metab. 1979 Jan;48(1):1–4. doi: 10.1210/jcem-48-1-1. [DOI] [PubMed] [Google Scholar]
  20. Kodama K., Sikorska H., Bandy-Dafoe P., Bayly R., Wall J. R. Demonstration of a circulating autoantibody against a soluble eye-muscle antigen in Graves' ophthalmopathy. Lancet. 1982 Dec 18;2(8312):1353–1356. doi: 10.1016/s0140-6736(82)91267-3. [DOI] [PubMed] [Google Scholar]
  21. Kriss J. P., Konishi J., Herman M. Studies on the pathogenesis of Graves' ophthalmopathy (with some related observations regarding therapy). Recent Prog Horm Res. 1975;31:533–566. doi: 10.1016/b978-0-12-571131-9.50018-9. [DOI] [PubMed] [Google Scholar]
  22. Lane R. J., Mastaglia F. L. Drug-induced myopathies in man. Lancet. 1978 Sep 9;2(8089):562–566. doi: 10.1016/s0140-6736(78)92894-5. [DOI] [PubMed] [Google Scholar]
  23. Massey D. G., Becklake M. R., McKenzie J. M., Bates D. V. Circulatory and ventilatory response to exercise in thyrotoxicosis. N Engl J Med. 1967 May 18;276(20):1104–1112. doi: 10.1056/NEJM196705182762002. [DOI] [PubMed] [Google Scholar]
  24. Mastaglia F. L., Barwich D. D., Hall R. Myopathy in acromegaly. Lancet. 1970 Oct 31;2(7679):907–909. doi: 10.1016/s0140-6736(70)92072-6. [DOI] [PubMed] [Google Scholar]
  25. Mastaglia F. L. Pathological changes in skeletal muscle in acromegaly. Acta Neuropathol. 1973;24(4):273–286. doi: 10.1007/BF00685584. [DOI] [PubMed] [Google Scholar]
  26. McFadzean A. J., Yeung R. Periodic paralysis complicating thyrotoxicosis in Chinese. Br Med J. 1967 Feb 25;1(5538):451–455. doi: 10.1136/bmj.1.5538.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. McKeran R. O., Slavin G., Andrews T. M., Ward P., Mair W. G. Muscle fibre type changes in hypothyroid myopathy. J Clin Pathol. 1975 Aug;28(8):659–663. doi: 10.1136/jcp.28.8.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Munro R. E., Lamki L., Row V. V., Volpé R. Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test. J Clin Endocrinol Metab. 1973 Aug;37(2):286–292. doi: 10.1210/jcem-37-2-286. [DOI] [PubMed] [Google Scholar]
  29. Patten B. M., Bilezikian J. P., Mallette L. E., Prince A., Engel W. K., Aurbach G. D. Neuromuscular disease in primary hyperparathyroidism. Ann Intern Med. 1974 Feb;80(2):182–193. doi: 10.7326/0003-4819-80-2-182. [DOI] [PubMed] [Google Scholar]
  30. Pickett J. B., Layzer R. B., Levin S. R., Scheider V., Campbell M. J., Sumner A. J. Neuromuscular complications of acromegaly. Neurology. 1975 Jul;25(7):638–645. doi: 10.1212/wnl.25.7.638. [DOI] [PubMed] [Google Scholar]
  31. Prineas J., Hall R., Barwick D. D., Watson A. J. Myopathy associated with pigmentation following adrenalectomy for Cushing's syndrome. Q J Med. 1968 Jan;37(145):63–77. [PubMed] [Google Scholar]
  32. Puvanendran K., Cheah J. S., Wong P. K. Electromyographic (EMG) study in thyrotoxic periodic paralysis. Aust N Z J Med. 1977 Oct;7(5):507–510. doi: 10.1111/j.1445-5994.1977.tb03372.x. [DOI] [PubMed] [Google Scholar]
  33. Shoji S., Takagi A., Sugita H., Toyokura Y. Dysfunction of sarcoplasmic reticulum in rabbit and human steroid myopathy. Exp Neurol. 1976 May;51(2):304–309. doi: 10.1016/0014-4886(76)90255-7. [DOI] [PubMed] [Google Scholar]
  34. Snowdon J. A., Macfie A. C., Pearce J. B. Hypocalcaemic myopathy with paranoid psychosis. J Neurol Neurosurg Psychiatry. 1976 Jan;39(1):48–52. doi: 10.1136/jnnp.39.1.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Solomon D. H., Chopra I. J., Chopra U., Smith F. J. Identification of subgroups of euthyroid graves's ophthalmopathy. N Engl J Med. 1977 Jan 27;296(4):181–186. doi: 10.1056/NEJM197701272960401. [DOI] [PubMed] [Google Scholar]
  36. Teng C. S., Smith B. R., Clayton B., Evered D. C., Clark F., Hall R. Thyroid-stimulating immunoglobulins in ophthalmic Graves' disease. Clin Endocrinol (Oxf) 1977 Mar;6(3):207–211. doi: 10.1111/j.1365-2265.1977.tb03316.x. [DOI] [PubMed] [Google Scholar]
  37. Tomas F. M., Munro H. N., Young V. R. Effect of glucocorticoid administration on the rate of muscle protein breakdown in vivo in rats, as measured by urinary excretion of N tau-methylhistidine. Biochem J. 1979 Jan 15;178(1):139–146. doi: 10.1042/bj1780139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Werner S. C., Coleman D. J., Franzen L. A. Ultrasonographic evidence of a consistent orbital involvement in Graves's disease. N Engl J Med. 1974 Jun 27;290(26):1447–1450. doi: 10.1056/NEJM197406272902602. [DOI] [PubMed] [Google Scholar]
  39. Wiles C. M., Young A., Jones D. A., Edwards R. H. Muscle relaxation rate, fibre-type composition and energy turnover in hyper- and hypo-thyroid patients. Clin Sci (Lond) 1979 Oct;57(4):375–384. doi: 10.1042/cs0570375. [DOI] [PubMed] [Google Scholar]
  40. Wilson R. W., Ward M. D., Johns T. R. Corticosteroids: a direct effect at the neuromuscular junction. Neurology. 1974 Nov;24(11):1091–1095. doi: 10.1212/wnl.24.11.1091. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES